We are live on
!
Find out more
EP
Evelyn Partners Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
550
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Abbott
ABT
$174B
| $5.6M | 0.01% |
+61,765
| New | +$5.64M |
|
102
Xylem
XYL
$23.5B
| $5.51M | 0.01% |
+46,616
| New | +$5.38M |
|
103
PepsiCo
PEP
$175B
| $5.46M | 0.01% |
+40,319
| New | +$6.03M |
|
104
Williams Companies
WMB
$83.3B
| $5.21M | 0.01% |
+70,112
| New | +$5.16M |
|
105
McCormick & Company Voting
MKC.V
$13.2B
| $5.21M | 0.01% |
+103,284
| New | +$5.07M |
|
106
Cadence Design Systems
CDNS
$88.8B
| $5.21M | 0.01% |
+13,878
| New | +$4.86M |
|
107
Roper Technologies
ROP
$34.6B
| $5.12M | 0.01% |
+15,127
| New | +$5.16M |
|
108
L3Harris
LHX
$43.8B
| $4.92M | 0.01% |
+16,942
| New | +$5.38M |
|
109
RELX
RELX
$57.5B
| $4.85M | 0.01% |
+153,281
| New | +$5.19M |
|
110
ASML
ASML
$702B
| $4.54M | 0.01% |
+2,282
| New | +$3.63M |
|
111
SLB Ltd
SLB
$73.6B
| $4.42M | 0.01% |
+95,075
| New | +$5.1M |
|
112
Rockwell Automation
ROK
$47.8B
| $4.38M | 0.01% |
+8,852
| New | +$3.85M |
|
113
Caterpillar
CAT
$380B
| $4.38M | 0.01% |
+4,109
| New | +$3.61M |
|
114
Colgate-Palmolive
CL
$68.8B
| $4.18M | 0.01% |
+45,589
| New | +$3.99M |
|
115
Canadian Pacific Kansas City
CP
$75.9B
| $4.14M | 0.01% |
+47,825
| New | +$4.1M |
|
116
Toronto Dominion Bank
TD
$195B
| $4.13M | 0.01% |
+33,989
| New | +$3.72M |
|
117
Verizon
VZ
$192B
| $3.93M | 0.01% |
+92,830
| New | +$4.35M |
|
118
iShare MSCI Eurozone ETF
EZU
$9.56B
| $3.69M | 0.01% |
+63,236
| New | +$4.26M |
|
119
Sherwin-Williams
SHW
$79.8B
| $3.46M | 0.01% |
+10,050
| New | +$3.21M |
|
120
Citigroup
C
$220B
| $3.45M | 0.01% |
+24,653
| New | +$3.21M |
|
121
MSCI
MSCI
$39B
| $3.41M | 0.01% |
+6,081
| New | +$3.55M |
|
122
Accenture
ACN
$107B
| $3.33M | 0.01% |
+26,771
| New | +$4.65M |
|
|
MICC
123
The Magnum Ice Cream Company N.V.
MICC
$11.2B
| $3.31M | 0.01% |
+189,966
| New | +$2.96M |
|
124
Tesla
TSLA
$1.4T
| $2.87M | 0.01% |
+6,815
| New | +$2.71M |
|
125
Motorola Solutions
MSI
$74.1B
| $2.79M | 0.01% |
+6,717
| New | +$2.81M |
|
Similar funds
VCMC
SCP
Evelyn Partners's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.